NIKKEI 225
28,591.05 -213.80 (-0.74%) HANG SENG
26,133.43 +6.50 (+0.02%) GOLD FUTURES
1,799.60 +3.30 (+0.18%) DOW
35,677.02 +73.92 (+0.21%) BTC-GBP
44,913.62 +438.57 (+0.99%) CMC Crypto 200
1,453.34 -49.70 (-3.31%)
Nexstim Plc (NXTMS.ST)
- Globe Newswire
Nexstim Releases the New NBS5+ in the United States
Press release, Helsinki, 22 October 2021 at 9 AM (EEST) Nexstim Releases the New NBS5+ in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the launch of a new navigated transcranial magnetic stimulation (nTMS) system configuration in the United States, to further strengthen competitive advantage in this market. The US will now have access to a new NBS (Navigated Brain Stimulation) System 5 configuration, NBS5+. The new configuration adds the NBT® (Navigated
- Globe Newswire
Nexstim Plc Business and Clinical Update Q3 2021
Press release, Helsinki, 20 October 2021 at 10:00 AM (EEST) Nexstim Plc Business and Clinical Update Q3 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of the Company’s business and clinical progress during Q3 2021. CEO Mikko Karvinen’s Business and Clinical Update I’m very happy to inform that following the strongest first half in the history of the company, our operational business has continued to show positive progress during the third quarter of
- Globe Newswire
Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury
Press release, Helsinki, 15 October 2021 at 9 AM (EEST) Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a research project utilizing the Company’s SmartFocus® TMS technology has been awarded the Human Brain Project (HBP) Innovation Award. Professor Marcello Massimini and his team from the Department of Clinical and Biomedical Sciences at Un
